Asset Details
Do you wish to reserve the book?
Receptor for Advanced Glycation End Products (RAGE): A Pivotal Hub in Immune Diseases
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Receptor for Advanced Glycation End Products (RAGE): A Pivotal Hub in Immune Diseases
Do you wish to request the book?
Receptor for Advanced Glycation End Products (RAGE): A Pivotal Hub in Immune Diseases
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Receptor for Advanced Glycation End Products (RAGE): A Pivotal Hub in Immune Diseases
2022
Overview
As a critical molecule in the onset and sustainment of inflammatory response, the receptor for advanced glycation end products (RAGE) has a variety of ligands, such as advanced glycation end products (AGEs), S100/calcium granule protein, and high-mobility group protein 1 (HMGB1). Recently, an increasing number studies have shown that RAGE ligand binding can initiate the intracellular signal cascade, affect intracellular signal transduction, stimulate the release of cytokines, and play a vital role in the occurrence and development of immune-related diseases, such as systemic lupus erythematosus, rheumatoid arthritis, and Alzheimer’s disease. In addition, other RAGE signaling pathways can play crucial roles in life activities, such as inflammation, apoptosis, autophagy, and endoplasmic reticulum stress. Therefore, the strategy of targeted intervention in the RAGE signaling pathway may have significant therapeutic potential, attracting increasing attention. In this paper, through the systematic induction and analysis of RAGE-related signaling pathways and their regulatory mechanisms in immune-related diseases, we provide theoretical clues for the follow-up targeted intervention of RAGE-mediated diseases.
Publisher
MDPI AG,MDPI
Subject
advanced glycation end-product receptor
/ Collagen
/ Glycation End Products, Advanced - metabolism
/ high-mobility group protein 1
/ Humans
/ immune
/ Immune System Diseases - metabolism
/ Kinases
/ Ligands
/ Lupus
/ Proteins
/ Receptor for Advanced Glycation End Products - genetics
/ Receptor for Advanced Glycation End Products - metabolism
/ Review
